Cell surface glycan engineering of neural stem cells augments neurotropism and improves recovery in a murine model of multiple sclerosis.
about
Quantitative Characterization of E-selectin Interaction with Native CD44 and P-selectin Glycoprotein Ligand-1 (PSGL-1) Using a Real Time Immunoprecipitation-based Binding Assay.Fulfilling Koch's postulates in glycoscience: HCELL, GPS and translational glycobiology.Endogenous repair and development inspired therapy of neurodegeneration in progressive multiple sclerosis.Current Understanding of the Pathways Involved in Adult Stem and Progenitor Cell Migration for Tissue Homeostasis and Repair.T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.A Glycovariant of Human CD44 is Characteristically Expressed on Human Mesenchymal Stem Cells.Advances in cell surface glycoengineering reveal biological function.Glycoengineering of E-Selectin Ligands by Intracellular versus Extracellular Fucosylation Differentially Affects Osteotropism of Human Mesenchymal Stem Cells.Methods and practices to diversify cell-based products.Expression and Characterization of Human β-1, 4-Galactosyltransferase 1 (β4GalT1) Using Silkworm-Baculovirus Expression System.Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies.Therapeutic Neural Stem Cells Engineered During Different Stages of Reprogramming Reveal Varying Therapeutic Efficacies.E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy.Improving Immunotherapy Through Glycodesign
P2860
Q27313560-19684F3E-29BA-454A-A085-8AEF12BFD620Q36843250-FFA4A239-0617-42F7-BE65-6BEEAC092126Q38765008-6B60CADC-8C73-4FCB-B641-BFFAB5171E4BQ38840851-108D42C6-5CDE-49DF-9053-6A96C2F8834EQ38873974-92E67F08-DCDD-4F91-BCCA-79B5C3290EE8Q39152658-3D257D29-2E05-42A4-8DD2-E148F5BD620CQ41058896-2B76D456-C58A-4372-BA24-2BC01B925C68Q41657642-928AF340-6281-42C2-ACC1-5328CEA684CFQ47246973-B2525421-7E83-44B0-AF38-3151B5FD208CQ47840988-03F5B7F4-B38D-4148-B99B-73E4EBF98649Q48117495-B013F42B-AF54-4787-AA32-A1FC7C9571DEQ49936618-DC1D230B-46EC-40C9-92B6-F370ACB39269Q50197234-A495A031-06D7-49A5-A790-65319BF77D8CQ59132146-7996D0F2-844C-476F-B0ED-0048981AD13C
P2860
Cell surface glycan engineering of neural stem cells augments neurotropism and improves recovery in a murine model of multiple sclerosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cell surface glycan engineerin ...... e model of multiple sclerosis.
@ast
Cell surface glycan engineerin ...... e model of multiple sclerosis.
@en
type
label
Cell surface glycan engineerin ...... e model of multiple sclerosis.
@ast
Cell surface glycan engineerin ...... e model of multiple sclerosis.
@en
prefLabel
Cell surface glycan engineerin ...... e model of multiple sclerosis.
@ast
Cell surface glycan engineerin ...... e model of multiple sclerosis.
@en
P2093
P2860
P50
P356
P1433
P1476
Cell surface glycan engineerin ...... e model of multiple sclerosis.
@en
P2093
Jaime Imitola
Marta Olah
Robert Sackstein
Samia J Khoury
P2860
P304
P356
10.1093/GLYCOB/CWV046
P577
2015-07-07T00:00:00Z